Rhinocort Aqua

This page contains recent news articles, when available, and an overview of Rhinocort Aqua but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Rhinocort Aqua
(when available)

Pharmacology and use:
Budesonide is a synthetic corticosteroid indicated for the treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon. Budesonide is used in Crohn's disease to decrease the symptoms and inflammation associated with the disease, especially at times of flare up. Budesonide has a high topical glucocorticosteroid (GCS) activity and a substantial first pass elimination. The formulation contains granules which are coated to protect dissolution in gastric juice, but which dissolve at pH >5.5, ie, normally when the granules reach the duodenum. Thereafter, a matrix of ethylcellulose with budesonide controls the release of the drug into the intestinal lumen in a time-dependent manner. For the treatment of mild to moderate active Crohn's disease.

Mechanism Of Action:
The exact mechanism of action of budesonide in the treatment of Crohn's disease is not fully understood. However, being a glucocorticosteroid, budesonide has a high local anti-inflammatory effect.

News Articles on Budesonide

AstraZeneca and Harte-Hanks Honored at the 2007 Medical Marketing …  -  Jun 12, 2007
Harte-Hanks was engaged to help AstraZeneca find an appealing and effective way to promote RHINOCORT AQUA to health care professionals, to generate requests ... Free with registration - PR Newswire - AccessMyLibrary.com

Gauging medicine risks for the pregnant, FDA revises list of safe...  -  Oct 18, 2005
The corticosteroid nasal spray Rhinocort Aqua (budesonide) was moved into this class last year from Category C, where many allergy and asthma drugs reside. ... Pay-Per-View - Newsday - ProQuest Archiver

Press Release: Survey Shows Discomfort With Existing Nasal Sprays …  -  Feb 26, 2007
Article: RHINOCORT AQUA(R) (budesonide) First and Only Intranasal ... PR Newswire; August 26, ... RHINOCORT AQUA Nasal Spray is administered ... women. ... Pay-Per-View - PR Newswire - HighBeam Research

AstraZeneca, with HarteHanks, garnered a bronze award in the Physician...  -  Jul 1, 2007
AstraZeneca, with HarteHanks, garnered a bronze award in the Physician, Direct Mail category for its "Rhino Reader" campaign to promote Rhinocort Aqua ... $9.94 - Pharmaceutical Executive - Alacra Store

Chronic sinusitis  -  Oct 11, 2008
Examples include fluticasone (Flonase), budesonide (Rhinocort Aqua), triamcinolone (Nasacort AQ), mometasone (Nasonex) and beclomethasone (Beconase). ... CNN International

FDA Approves New Nasal Spray for Hay Fever  -  Oct 26, 2006
Other steroid nasal sprays that are already available include Flonase, Nasonex, Rhinocort Aqua, Nasacort AQ, and Nasarel. By Jennifer Warner, reviewed by ... FOXNews

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target. APD791 (5-HT2A Serotonin Receptor ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target. Actimmune (Interferon Gamma-1b) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target. INCB18424 (Janus-Associated Kinase ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target. Qnexa (Phentermine/Topiramate) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target ... $250.00 - Revere Reports - Revere

How Common Drugs Compare on Safety in Pregnancy  -  Oct 11, 2005
The corticosteroid nasal spray Rhinocort Aqua (budesonide) was moved into this class last year from Category C, where many allergy and asthma drugs reside. ... Washington Post

How Common Drugs Compare on Safety in Pregnancy | Article from The …  -  Oct 11, 2005
The corticosteroid nasal spray Rhinocort Aqua (budesonide) was moved into this class last year from Category C, where many allergy and asthma drugs reside. ... Pay-Per-View - Washington Post - HighBeam Research

Press Release: Landmark 'Pediatric Allergies in America' Survey …  -  Mar 17, 2008
RHINOCORT AQUA ... patients suffering from seasonal or year-round allergic rhinitis ... Article: RHINOCORT AQUA(R) (budesonide) First and Only Intranasal . ... Pay-Per-View - PR Newswire - HighBeam Research

Look Ma, No Preservatives!  -  Apr 20, 2005
Which means that your Rhinocort Aqua won't need preservatives anymore, which means less irritation of the mucous membranes and fewer side effects. ... Medgadget.com

Article: Mixed reaction to firing at AstraZeneca: AstraZeneca's...  -  Apr 10, 2007
...ePromotions Manager for AstraZeneca (US) - RHINOCORT AQUA ... partner with UV on behalf of AstraZeneca to debut the first pharmaceutical ... said Eric ... Pay-Per-View - Philadelphia Inquirer - HighBeam Research

Free drug samples may not be a great deal  -  Oct 6, 2008
4. Strattera, for ADHD (Lilly). 5. Albuterol, for asthma (Merck). 6. Elidel, for eczema (Novartis). 7. Rhinocort Aqua, for nasal allergies (AstraZeneca) Pay-Per-View - USA TODAY - ProQuest Archiver

New Studies Reveal What Caregivers See as Key Issues to Facilitate …  -  Nov 13, 2006
Through innovative respiratory products, including SYMBICORT(R), PULMICORT RESPULES(R), PULMICORT TURBUHALER(R), and RHINOCORT AQUA(R), AstraZeneca is ... Free with registration - PR Newswire - AccessMyLibrary.com

PREGNANCY POSES EXTRA RISKS FROM DRUGS  -  Oct 23, 2005
The corticosteroid nasal spray Rhinocort Aqua (budesonide) was moved into this class last year from Category C, where many allergy and asthma drugs reside. ... Pay-Per-View - South Florida Sun - Sentinel - ProQuest Archiver

== Janusinfo - läkemedelsinformation för sjukvÃ¥rden ==  -  Jun 18, 2008
Rhinocort Aqua är nu rekommenderad nasal steroid vid indikationerna allergisk ... Rhinocort Aqua innehåller samma aktiva substans (budesonid) och samma ... Janus

Once- or Twice-Daily Treatment With PULMICORT RESPULES(R) …  -  Nov 14, 2006
Through innovative respiratory products, including SYMBICORT(R), PULMICORT RESPULES(R), PULMICORT TURBUHALER(R), and RHINOCORT AQUA(R), AstraZeneca is ... Medical News Today - Medical News Today (press release)

Allergy alarm: what with seasonal demand, over-the-counter switches,...  -  Apr 1, 2006
Rounding out the corticosteroid category are Sanofi-Aventis' Nasacort AQ (triamcinolone acetonide), AstraZeneca's Rhinocort Aqua (budesonide) and GSK's ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Are common drugs safe during pregnancy?  -  Nov 14, 2005
The corticosteroid nasal spray Rhinocort Aqua (budesonide) was moved into this class last year from Category C, where many allergy and asthma drugs reside. ... Pay-Per-View - Wichita Eagle - Factiva, from Dow Jones

Collegium Pharmaceutical Provides Update on Development of its Nasal ...  -  Aug 15, 2007
Competing inhaled steroid products in this category include Nasonex(R) (Schering), Nasacort(R) (Aventis) and Rhinocort Aqua(R) (AstraZeneca). ... Genetic Engineering News - Genetic Engineering News (press release)

Top 200 brand-name drugs by units in 2005.(rankings )  -  Mar 20, 2006
80 Aricept 4292 7.5 81 Niaspan 4248 9.9 82 Depakote 4077 -13.4 83 Tri-Sprintec 4012 15.6 84 OxyContin 3967 -34.6 85 Rhinocort Aqua 3940 -11.7 86 Benicar ... Free with registration - Drug Topics - AccessMyLibrary.com

How to take Ciclesonide Nasal Spray from Consumer Reports Health.  -  Jan 4, 2007
...any other nasal corticosteroid such as beclomethasone (Beconase AQ), budesonide (Rhinocort Aqua), fluticasone (Flonase), momentasone (Flonase), ... consumerreports.org

Merger and Acquisition Scenario  -  Aug 19, 2006
Target (Total: 133). Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Business achievers for June 18  -  Jun 18, 2007
Association for Harte-Hanks' promotion of the company's Rhinocort Aqua nasal spray. The awards recognize the year's best medical marketing initiatives. ... phillyBurbs.com

Successful Internet Business Advertising Solutions  -  May 26, 2007
His clients included many renowned brands such as Pavulon, Norcuron, Zemuron, Rhinocort AQUA, Toprol-XL, Crestor, Nexium, and many more. ... webwire.com

AstraZeneca Pledges More Than $1 Million in Contributions and …  -  Sep 1, 2005
PULMICORT RESPULES(R) (budesonide inhalation suspension), PULMICORT TURBUHALER(R) (budesonide inhalation powder), RHINOCORT AQUA(R) (budesonide), ... $4.95 - PR Newswire - ECNext

Merger and Acquisition Scenario  -  Aug 19, 2006
Buyer (Total: 133). Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Best use of direct marketing to healthcare professionals.(Direct...  -  Nov 1, 2007
There were several challenges for Rhinocort Aqua, a scent-free and alcohol-free intranasal corticosteroid spray. It's a "comparatively mature brand," thus ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Global top 200 brand-name drugs ranked by retail sales in dollars and...  -  Feb 21, 2005
321984 16.4 91 Lidoderm 313786 69.0 92 Diflucan 312619 -27.9 93 Nasacort AQ 309590 9.5 94 Rhinocort Aqua 307406 6.0 95 Levoxyl 291498 -17.3 96 Zithromax ... $20.00 - Drug Topics - Alacra Store

Merger and Acquisition Scenario  -  Mar 11, 2006
Buyer (Total: 145). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Top 200 brand-name drugs by retail dollars in 2006.(COMMUNITY …  -  Feb 19, 2007
119 Boniva 270321 387.8 120 Zofran ODT 267379 24.9 121 Caduet 266446 91.3 122 Requip 260813 139.5 123 Fuzeon 256183 15.8 124 Rhinocort Aqua 254697 -14.1 ... Free with registration - Drug Topics - AccessMyLibrary.com

Merger and Acquisition Scenario  -  Dec 16, 2006
Buyer (Total: 148). CAT-213 (Anti-Eotaxin1 Antibody); Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist) ... $250.00 - Revere Reports - Revere

Childhood asthma: treatment update.  -  May 15, 2005
...(29) A brief, four-week study of oral montelukast (Singulair) added to standard dosages of inhaled budesonide (Rhinocort Aqua) in children whose asthma was ... $4.95 - American Family Physician - ECNext

Collegium Pharmaceutical Announces FDA Filing for AllerNase(TM), a …  -  Apr 8, 2008
Competing inhaled steroid products in this category include Nasonex(R) (Schering), Nasacort(R) (Aventis), Rhinocort Aqua(R) (AstraZeneca) and Veramyst(R) ... Genetic Engineering News - Genetic Engineering News (press release)

Basal and Cosyntropin-Stimulated Plasma Cortisol Concentrations, as …  -  Mar 13, 2007
...younger than 6 yr with AR who were treated with budesonide aqueous nasal spray (Rhinocort Aqua; AstraZeneca LP; 64 µg once daily) or matching placebo. ... Journal of Clinical Endocrinology and...

Merger and Acquisition Scenario  -  May 13, 2006
Buyer (Total: 146). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Triptan nasal spray is effective vs. migraine in adolescents.(Clinical...  -  Nov 1, 2005
Rhinocort Aqua (budesonide) nasal spray is a water-based formulation of Rhinocort Nasal Spray intended for once-a-day dosing. The spray is indicated for ... Pay-Per-View - Family Practice News - HighBeam Research

Survival Tips to Help You Get Through the Fall Allergy Season  -  Sep 8, 2008
INS has become cornerstone in managing persistent nasal allergy (some examples include Flonase, Nasonex, Rhinocort Aqua, Veramyst and Nasacort AQ). ... HealthCentral.com

Merger and Acquisition Scenario  -  Dec 16, 2006
Buyer (Total: 148). CAT-213 (Anti-Eotaxin1 Antibody); Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Apr 7, 2007
Buyer (Total: 151). Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist); Toprol-XL (Metoprolol Succinate) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Oct 21, 2006
Buyer (Total: 150). CAT-213 (Anti-Eotaxin1 Antibody); Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist) ... $250.00 - Revere Reports - Revere

United States top 200 brand-name drugs by retail sales in dollars and...  -  Mar 6, 2006
Truvada 326641 >999 100 Zelnorm 318220 26.4 101 Reyataz 313778 37.6 102 Nasacort AQ 311467 0.6 103 Sustiva 309140 4.2 104 Rhinocort Aqua 296463 -3.6 105 ... $20.00 - Drug Topics - Alacra Store

Article: MM&M Awards 2008: this is your year: the quest to win an...  -  Feb 1, 2008
Harte-Hanks and AstraZeneca for Rhinocort Aqua, Ogilvy Healthworld and Wyeth for know Menopause.com, while Abelson Taylor scooped six awards in all, ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

United States top 200 brand-name pharmaceuticals by retail sales in …  -  Feb 19, 2007
119 Boniva 270321 387.8 120 Zofran ODT 267379 24.9 121 Caduet 266446 91.3 122 Requip 260813 139.5 123 Fuzeon 256183 15.8 124 Rhinocort Aqua 254697 -14.1 ... $20.00 - Drug Topics - Alacra Store

Merger and Acquisition Scenario  -  Nov 25, 2006
Buyer (Total: 149). CAT-213 (Anti-Eotaxin1 Antibody); Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jan 27, 2007
Buyer (Total: 150). CAT-213 (Anti-Eotaxin1 Antibody); Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 22, 2008
Buyer (Total: 187). Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jul 21, 2007
Buyer (Total: 187). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Global top 300 brand-name pharmaceuticals by sales, manufacturer, and...  -  Apr 28, 2008
Astelin 00037024130 153 AstraZeneca Rhinocort Aqua 00186107008 154 McNeil Topamax 00045064265 155 Novartis Diovan HCT 00078031434 156 GlaxoSmithKline ... $20.00 - Chain Drug Review - Alacra Store

Merger and Acquisition Scenario  -  Apr 15, 2006
Buyer (Total: 145). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target. EUR-1000 (Long Acting Propranolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Dec 27, 2008
Buyer (Total: 188). Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Nov 29, 2008
Buyer (Total: 186). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

A new Web site.(Update)(Website overview) | Article from Medical …  -  Jul 1, 2007
Medical Marketing & Media; December 1, 2001 ; 700+ words ... ... industry of new "floating" Internet ads with two promotions for its Rhinocort Aqua ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Bucks County Courier Times : LOCAL<br>  -  Jun 15, 2007
Association for Harte-Hanks' promotion of the company's Rhinocort Aqua nasal spray. The awards recognize the year's best medical marketing initiatives. ... $3.50 - Bucks County Courier Times - NewsBank

Merger and Acquisition Scenario  -  Jul 28, 2007
Buyer (Total: 187). Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Nov 22, 2008
Buyer (Total: 186). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Nov 1, 2008
Buyer (Total: 186). Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  May 17, 2008
Buyer (Total: 186). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Competitors by Product Report  -  Mar 29, 2008
AstraZeneca plc (ADR) (AZN) Products:. Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide). Barr Pharmaceuticals, Inc. (BRL) Products: ... $75.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 13, 2008
Target (Total: 186). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Nov 4, 2006
Buyer (Total: 150). CAT-213 (Anti-Eotaxin1 Antibody); Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Dec 20, 2008
Buyer (Total: 188). Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Developmental decalage.(Perspectives on Parenting) | Article from …  -  Dec 1, 2007
Recently Rhinocort Aqua, a nasal steroid spray, was approved for children six years of age and older. It's the first once-a-day nasal steroid spray to ... Pay-Per-View - Pediatrics for Parents - HighBeam Research

Merger and Acquisition Scenario  -  Jan 26, 2008
Buyer (Total: 187). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Omnaris nasal spray.(New & Approved)(Drug overview) | Article from …  -  Feb 1, 2008
Rhinocort Aqua (budesonide) nasal spray is a water-based formulation of Rhinocort Nasal Spray intended for once-a-day dosing. The spray is indicated for ... Pay-Per-View - Family Practice News - HighBeam Research

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target ... $250.00 - Revere Reports - Revere

Competitors by Product Report  -  Dec 20, 2008
AstraZeneca plc (ADR) (AZN) Products:. Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide). GlaxoSmithKline plc (ADR) (GSK) Products: ... $75.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jan 26, 2008
Buyer (Total: 187). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 2, 2008
Buyer (Total: 186). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target. EW-A-401 (Zinc Finger DNA-Binding ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Dec 13, 2008
Buyer (Total: 187). Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target. Twinject Epinephrine Auto-Injector ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 8, 2008
Buyer (Total: 187). Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target. Chore Boy; Cutex; Denorex; Prell ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jun 16, 2007
Buyer (Total: 151). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Apr 5, 2008
Target (Total: 186). Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 6, 2008
Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol). Target. rFactor XIII; Interleukin 22 ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  May 19, 2007
Buyer (Total: 151). Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist); Toprol-XL (Metoprolol Succinate) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Apr 12, 2008
Target (Total: 186). Rhinocort Nasal Inhaler (Budesonide); Rhinocort Aqua (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jul 12, 2008
Buyer (Total: 186). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 13, 2008
Buyer (Total: 186). Rhinocort Aqua (Budesonide); Rhinocort Nasal Inhaler (Budesonide); AZD6140 (ADP Antagonist); Tenormin (Atenolol) ... $250.00 - Revere Reports - Revere

Top 200 brand name drugs by units in 2006.(COMMUNITY PRACTICE)( …  -  Mar 5, 2007
3230 -10.5 100 Boniva 3194 371.8 101 Zyrtec-D 3184 -0.5 102 Rhinocort Aqua 3178 -19.4 103 Levothroid 2988 -13.4 104 Tussionex 2973 -10.1 105 Kariva 2910 ... $4.95 - Drug Topics - ECNext

Top 200 brand-name drugs by retail dollars in 2006.(COMMUNITY …  -  Feb 19, 2007
119 Boniva 270321 387.8 120 Zofran ODT 267379 24.9 121 Caduet 266446 91.3 122 Requip 260813 139.5 123 Fuzeon 256183 15.8 124 Rhinocort Aqua 254697 -14.1 ... $4.95 - Drug Topics - ECNext

Macklin v. Kelly, No. 04-C-536 (EDWis. 03/31/2006)  -  Mar 31, 2006
J. Exs.) Plaintiff was given Vioxx, Naprosyn and Vicodin for arthritis pain, Celexa and Trazodone for depression, Midrin for headaches, Rhinocort Aqua for ... $2.95 - U.S. District Court, Eastern District... - VersusLaw

Article: During pregnancy; allergic rhinitis could pass to child.(Clin...  -  Jun 1, 2007
Article: RHINOCORT AQUA(R) (budesonide) First and Only Intranasal ... PR Newswire; August 26, 2004 ; 700+ words ... ... treatment of allergic rhinitis are ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Article: You've got a screw loose; DOCS TELL TOT WITH BREATHING …  -  Mar 23, 2006
Article: RHINOCORT AQUA(R) (budesonide) First and Only Intranasal ... PR Newswire; August 26, 2004 ; 700+ words ... ... covered over 2000 births from ... Pay-Per-View - Daily Record - HighBeam Research

Brand Names/Synonyms:
Rhinocort Aqua is also known by the following brand names and/or synonymsBidien; Budeson; Budesonide; Budesonide, Pharma; BudesonideÊ; Cortivent; Desonide; Desowen; Entocort; Entocort Ec; Micronyl; Preferid; Pulmicort; Pulmicort Nebuamp; Pulmicort Respules; Pulmicort Turbuhaler; Rhinocort; Rhinocort Aqua; Rhinocort Turbuhaler; Spirocort; Tridesilon

Drug Category:
Rhinocort Aqua is categorized under the following by the FDA: Bronchodilator Agents; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA06; ATC:D07AC09; ATC:R01AD05; ATC:R03BA02

Dosage Forms:
CAPSULE (SUSTAINED-RELEASE); METERED-DOSE (AEROSOL); SUSPENSION

Absorption:
Complete

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
Not Available





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy